Wexford Capital LP Essa Pharma Inc. Transaction History

Wexford Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $81,900 - $150,990	-10,500 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$11.61 - $32.08 $87,655 - $242,204	7,550 Added 255.93%	10,500 $305,000
Q4 2020 Feb 16, 2021	SELL	$5.47 - $12.1 $109,673 - $242,605	-20,050 Reduced 87.17%	2,950 $35,000
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $118,200 - $153,463	19,700 Added 596.97%	23,000 $159,000
Q2 2020 Aug 13, 2020	BUY	$3.71 - $6.2 $12,243 - $20,460	3,300 New	3,300 $20,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.4M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.